The basic defect in lepromatous leprosy is the selective unresponsiveness of T cells to the antigens of Mycobacterium leprae (1). This defect may be partial or complete (2) and does not appear to change with prolonged chemotherapy (3). A lack of T cell-derived lymphokines such as IFN-y and IL-2 could account for the inability of macrophages and other cells to eliminate M. leprae .
(Southern Micro Instruments, Inc., Atlanta, GA). The distance from the epidermal-dermal junction to the outer surface of the epidermis was measured at equal intervals along the length of the sections . At least 25 measurements were made per section. Results were expressed as the ratio of mean thickness of the IL-2-injected site vs . the control site for each patient.
EM A part of each biopsy was processed for transmission EM studies. Biopsies were washed in saline at 4°C, cut into 1-2-mm pieces, and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer with 0.1 M sucrose, pH 7.4, for 16 h at 40C . The tissues were cut to 1 mm or smaller and postfixed in 2% Os04 for 6 h at 40C. The tissue was then stained en block for 2 h with 0.25% uranyl acetate, dehydrated in increments with ethanol, and embedded in epon blocks . Semi-thin sections were stained with methylene blue-azur-basic fuchsin and examined for areas containing infiltrating cells. Sections were stained with uranyl acetate and lead citrate, and examined with a transmission EM (model JEM 100CX; Jeol USA, Peabody, MA). At least 200 cells from each patient were examined and photographed on Kodak electron image film .
Results
Local IL-2 Responsiveness ofLepmmatous Patients. The local reaction to the intradermal injection of a single dose of 10 or 25 ug of rIL-2 into apparently normal skin of lepromatous leprosy patients is shown in Fig. 1 A . All the injected patients responded to the injection of IL-2. The extent of induration (radius of indurated area) was proportional to the dose oflymphokine administered both at 24 and 48 h after injection . Induration peaked at 24 h and decreased at 48 h, to a level that persisted for 4-7 d (not shown) . This response is comparable with a strong delayed-type hypersensitivity (DTH) response, but DTH usually persists for at least 96 h without any decrease (10) . The local response to multiple doses of 10 FAg IL-2 given at 48-h intervals is shown in Fig. 1 B. As in the previous group of patients, the initial induration after the first, second, and third injection (24, 72 , and 120 h) was reduced 24 h later at 48, 96, and 144 h, respectively. The area of induration induced by the first injection was not enhanced by subsequent injections . On the contrary, the third injection did not lead to induration above the basal level observed at 48 and 96 h. This suggested an unresponsiveness to IL-2 at 96 h. The basal induration observed at 96 and 144 h persisted for up to 2 wk. By 3 wk after lymphokine administration, 8-10 mm of induration was still observed in about half of the patients biopsied at that time (not shown) . Other than an erythematous skirt about the 24-h site, no other local or systemic reactions were noted.
The Local Cellular Response to rIL-2 Administration. Histological and immunohistological sections of IL-2-injected and control sites biopsied 2-21 d after lymphokine administration were used for the evaluation of the local cellular response to lym-FIGURE 2. The extent of dermal infiltration in response to rIL-2. Immunohistologic staining of cryostat sections with anti-Ia. Biopsies were taken from a patient (Table I, patient 4) at timephokine. The control sites taken from nonlesional "normal" skin contained an inflammatory infiltrate of lepromatous leprosy with perivascular aggregates of mononuclear leukocytes involving from <5-30% of the dermis (Fig. 2, a and b and Table I ) . Control biopsies taken from macular or nodular lepromatous lesions demonstrated dermal infiltration of 5-95% (Table I ) . The injection of rIL-2 into the skin induced an early extensive recruitment of new mononuclear cells that enhanced the percent of the dermis involved (Fig. 2, c and d) . The enhancement in cellularity was evaluated and expressed as the ratio of the area of dermis containing inflammatory cells in the IL-2 vs . the control site. As illustrated in Fig. 3 A, the increase in dermal, cellular infiltration was well established by 48 h, peaked at 4 d, and then subsided . By 3 wk the percent of the dermis involved at the IL-2 site had returned to the control level in the majority of patients .
The steep decline in cellularity after the last injection of IL-2 suggested that the lymphokine could be changing the normal turnover and or recirculation of the lym- 
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<6 + , patchy reduction, some areas 6 + , others 5 + or less . * The diagnosis was the histologic diagnosis of the control and IL-2 injected biopsies according to the Ridley Jopling scale . $ The reduction in BI is expressed in BI units (log units) and is the difference between the control and the IL-2 BI in the adjacent columns. t, <10-fold . S Granulomata were defined by the presence of epithelioid and multinucleated giant cells . B Subpolar lepromatous leprosy .
IL-2 injected into "normal skin" between nodular lesions . ** IL-2 injected into nodular lesions . All other patients injected into "normal skin" or macular lesions . T Cells and Their Subsets. The new inflammatory cells recruited by IL-2 could be identified as T lymphocytes and monocytes by their surface phenotype (Fig. 3) . At 48 h, the earliest time point examined in detail, the ratio of CD4+ to CD8+ T cells was over three times that observed in the control lepromatous skin and lesions (2 :1 vs . 0.6 :1) (Fig. 4 B) . In the absence of additional IL-2 administration, this ratio returned to control levels by the next day (Fig. 4 B, open triangle) . Repeated injections of rIL-2 maintained both a high number as well as a high ratio of CD4+/CD8 + cells. By 2 wk the ratio had returned to control levels in all patients while total cellularity was still above that found in the matched control sites. This could be the result of retention of mononuclear phagocytes and T cells and/or limited continued emigration .
Effect of IL-2 Administration on the Epidermis. Microscopic examination of the epidermis overlying the IL-2 sites revealed extensive epidermal thickening as compared with the matched control sites in all patients biopsied 2-4 d after IL-2 injection (Fig. 2) . The kinetics of thickening corresponded with the accumulation of cells in the dermis (Fig. 4 C) . site was observed. 3 wk after IL-2 administration the epidermis overlying the test site was almost normal in thickness in 9 of 13 patients tested at this time point .
Associated with the thickening of the epidermis were changes in the phenotype of the keratinocytes overlying these lesions. MHC class II antigen (Ia) and the IFN-,y-induced peptide IP-10 were expressed on keratinocytes after IL-2 (Figs. 4 D and  5, a and b) . Keratinocytes of control biopsies did not express these antigens (not shown) . Only 30-40% of individuals tested still expressed la and IP-10 on their ker- atinocytes at the site of IL-2 injection by 3 wk. Since la and IP-10 are both IFN-, y-responsiveness genes, these results are in keeping with the local release of IFN-, y .
Effect ofIL-2 Administration on the Distribution of T6+ Langerhans' Cells. In control lepromatous leprosy lesions, T6' Langerhans' cells were evenly distributed in the epidermis and absent from the dermis (23) . After IL-2 administration T6 + LC were prominent in the dermis by 72 h and persisted for as long as 3 wk (Fig . 5 c) . No modification in Langerhans' cell number or distribution was noted in the overlying epidermis as reported after PPD administration (23) .
Mononuclear Phagocyte Differentiation and the Selective Destruction of Parasitized Macrophages. After the IL-2-induced entry of new monocytes into the dermis, the cells differentiated into epithelioid and multinucleated giant cells (Fig. 6 b) . Epithelioid cell granulomas were observed 12 d after multiple injections of lymphokine and persisted for at least 3 wk (Table I ) . The differentiated mononuclear phagocytes of the granulomata were observed in association with lymphoid T cells of both the CD4+ and CD8+ phenotype.
Transmission EM revealed extensive local destruction of parasitized macrophages and foam cells in association with the accumulation of lymphoid cells in the IL-2-injected sites (Fig. 6 a) . Cellular dissolution and extracellular discharge of cell organelles, phagolysomes containing M. leprae, and free bacteria was prominent as early as 48 h after IL-2 injection.
LocalM. leprae Clearance. Associated with the destruction of parasitized and foamy macrophages, there was a reduction in the number of M. leprae of the lesion (Fig .  7 and Table I ) . A patchy reduction of up to 10-fold in M. leprae numbers was observed in six of seven patients biopsied as early as 48-72 h after IL-2 injection (Table  I) . In patients biopsied 4-21 d after IL-2 injection, a reduction of 10-1,000-fold in bacterial numbers was observed in 13 of 15 patients tested . This occurred both in nodular lesions as well as macular and diffuse lesions of "normal skin," and was associated with up-grading of the RidleyJopling diagnostic index.
Discussion
We have evaluated the cellular and microbial responses in the skin of LL/BL patients injected intradermally with 10-30 wg doses of rIL-2. In doing so, we have recapitulated the essential features of a cell-mediated immune response, previously established for an antigen-driven reaction to PPD (9, 10, (22) (23) (24) . These include extensive and persistent emigration of T cells and monocytes, the preponderance of T cells with a high CD4' /CD8 + ratio, the dermal accumulation of T6 + Langerhans' cells, the differentiation of mononuclear phagocytes to form granulomata, induction of expression of keratinocyte Ia and IP-10, and epidermal thickening.
In association with these events there is a striking, selective destruction of parasitized macrophages. We feel this destruction is an essential element in the subsequent disposal of M. leprae . We consider the resident infected dermal macrophage defective in those agents that can effectively kill and digest M. leprae within the phagolysosome (25, 26) . To expose these organisms to a less favorable intracellular milieu, one mechanism would involve the extracellular liberation of the bacteria and their subsequent uptake by newly emigrated, oxidatively competent monocytes (25) (26) (27) (28) . Prior in vitro studies indicate that blood-borne monocytes are responsive to the IFN-y produced (29) by CD4+ and CD8* T cells, NK, and LAK cells. All these cell types are likely candidates for local production of the lymphokine in the dermal site. Thus, working in concert, macrophage-activating lymphokines and newly emigrated monocytes are effective in the killing and degradation of viable M. leprae .
Our evidence for killing and degradation of M. leprae comes largely from quantitative morphological studies conducted at the light and electron microscopic level. The significant and consistent decline in local microbial load is quite remarkable when one considers the natural history of the disease . Even after microbicidal chemotherapy, the decline in nonviable organisms in the skin occurs at a rate of only 1 .0 BI units per year (30) . In contrast, IL-2 and the cellular response it evokes leads to the local disposal of 2-3 BI units in 3 wk or an increased removal of bacilli that exceeds the baseline rate by a factor of 20-200 . The response to IL-2 is more rapid and extensive than that observed either with PPD or rIFN-y (9, 10). Reductions in organisms occur within 1 wk of IL-2 injection and are as evident in the nodular lesions ofLL/BL patients and in so-called "normal" skin. rIFN-y modifies the bacillary load of nodular leprosy at a much slower rate (Kaplan et al., manuscript in preparation) .
The requirement for the selective destruction of parasitized macrophages is of considerable interest and may well apply to other situations in which bacteria or protozoal parasites lead to chronic infection . We have evidence that this occurs with the infected Kupffer cells of hepatic granuloma in murine Leishmanial infections (31) and in the local destruction ofLeishmania aethiopica-infected macrophages in chronic disseminated leishmaniasis in man after IL-2 administration (manuscript in preparation) . Observations made previously by us indicate that a similar scenario takes place in the natural lesions of paucibacillary tuberculoid leprosy and after the intradermal injection of PPD in presensitized lepromatous patients . In each of these instances, T cells have been observed in close contact with dead and dying epithelioid and foamy macrophages containing bacilli and bacillary products . Additional insights are now coming from the in vitro experiments of Hancock et al. (32) , which demonstrate the ability of CD4+ T cells to kill antigen (PPD)-pulsed macrophages in an antigen-dependent, MHC class II antigen-restricted way. Since many lepromatous patients fail to respond to specific M. leprae antigens, we suspect that crossreactive epitopes play a major role in the recognition of the parasitized macrophages in this form of toxicity. In addition, both NK cells and lymphokine-activated killer cells can play a less-specific role in macrophage destruction . Our in vitro studies suggest that PPD stimulation as well as exposure to rIL-2 generate an antigen-independent cytotoxic effector population that can kill monocytes in vitro.
The dermal induration and cell infiltration in response to IL-2 is briefer but more uniform than observed with antigens such as PPD. All patients respond to the lymphokine and the unresponsiveness to M. leprae does not appear to affect the responsiveness of IL-2 . The doses used in this study are miniscule when compared with the experience with antitumor therapy (33) but evoke both a local and systemic T cell response without untoward symptomatology. They are high relative to the amounts of IL-2 required for cellular activation in vitro (11, 12) . In studies to be reported elsewhere, PBMC from these patients showed more extensive proliferation (TdR incorporation) to antigens to which they have been previously sensitized after IL-2 injection . Obviously, many other questions remain concerning the effects of IL-2 when injected into the skin. Is it the primary or secondary chemoattractant that leads to extensive mononuclear cell emigration? What is the nature, source, and amount of induced molecules synthesized by activated cells in response to IL-2 administration? These questions are currently under investigation .
Finally, the use of IL-2 as a therapeutic agent requires additional information concerning its potential use for parenteral therapy. Studies in mice have shown that IL-2 administered subcutaneously can protect the animals against infections and enhance their immunity (34) (35) (36) . We do not know whether, ifused parenterally, IL-2 could enter and modify the dermis of LL/BL patients or whether local modifications ofendothelial permeability would be required. Parenteral IL-2 has been shown to activate the endothelium, enhance vascular permiability, and induce dermatological changes, including migration of T cells into the skin (37, 38) . These are questions for the future but ones that are pertinent for a wide range ofintracellular parasites.
Summary
Human rIL-2 (10-30 ug) was injected intradermally into the skin of patients with lepromatous leprosy with high bacillary loads . All patients responded to the lymphokine with local areas of induration that peaked at 24 h and persisted for 4-7 d irrespective of whether the site was "normal skin" or a nodular lesion . Starting at 48 h, there was an extensive destruction of mononuclear phagocytes that contained structurally intact or fragmented M. leprae observed at the electron microscope level. The organisms, either free or contained within endocytic vocuoles, were discharged into the extracellular space and then reingested by blood-borne monocytes. This was followed by marked reductions in the number ofacid-fast organisms in the injected site, evident as early as 4-7 d and more marked at 2-3 wk after injection . 13 of 15 patients exhibited a disposal of acid-fast bacilli ranging from 5-to 1,000-fold with a mean value of -100-fold .
The administration of IL-2 leads to the generation of an effective cell-mediated immune response, recapitulating an antigen-driven event and leading to striking local reductions in M. leprae . In comparison with the purified protein derivative of tuberculin reaction, bacilli are cleared more promptly, although emigratory cells persist for a shorter time.
We are grateful for the efforts of Sister Genet Amare at AHRI and Sister Ethiopia GebereYesus and the staff of the ALERT Leprosy Control, without whose help this study could not have been completed . Thanks are due to Dr. Yohannes Negesse and Kiros Ayenew for help with the histology. We thank Judy Adams for her help with the figures and Myrna Garcia for typing the manuscript.
